Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Christoph C. Carter, MD, PhD

Director, Clinical Research (MD)
Gilead Sciences

Disclosure(s): Gilead Sciences: Employee, Employee, Stocks/Bonds, Stocks/Bonds

Poster(s):

2059 - Estimated Background HIV Diagnosis Rates among People Who Could Benefit from Pre-Exposure Prophylaxis (PrEP) at the Metropolitan Statistical Area (MSA) level in the United States, 2012-2019
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
2079 - Comparison of Recency Assays to Estimate HIV Incidence in the SIENA (eStimating hIv incidEnce amoNg Agyw) Study in Uganda
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
2088 - Real-World Geographic Variations of HIV Diagnosis Rates among Individuals Prescribed and not Prescribed Oral HIV Pre-Exposure Prophylaxis (PrEP) Regimens in the United States
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET